A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy (in terms of weight and hemoglobin type
A1c [HbA1c]) and safety of topiramate (96 milligrams[mg] or 192 mg daily) with placebo in the
treatment of obesity in Type 2 diabetic patients receiving metformin.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.